Attacking Alzheimer's With Antibodies, Hormones
Pfizer called off additional studies of its intravenous drug bapineuzumab, an antibody designed to seek and destroy plaques that build up in the brains of people with Alzheimer's. The thinking was that if you clear the plaques, maybe the dementia will …
See all stories on this topic ยป
